Kevin Chaplin

Kevin Chaplin's Title

Kevin Chaplin holds the position of CEO at Kardium, a role he has excelled in since joining the company in 2008. As CEO, he is responsible for steering the strategic direction of the company, managing executive operations, and ensuring sustainable growth. His leadership has been integral to Kardium's advancements in cardiovascular technology, leveraging his extensive experience across various domains to drive the company forward.

Kevin Chaplin's Company

Kevin Chaplin is the CEO of Kardium, a medical technology company specializing in innovative solutions for the treatment of atrial fibrillation (AF). Under his leadership, Kardium has developed the Globe Mapping and Ablation System, a groundbreaking product that offers a comprehensive solution for AF treatment. Kevin's multifaceted role includes overseeing product development, marketing strategies, clinical trials, business development, and securing financing, all of which have contributed to Kardium's success and industry reputation.

Kevin Chaplin's Background

Before joining Kardium, Kevin Chaplin amassed a wealth of experience in various technical and managerial roles. He worked at Kodak, Sierra Wireless, and Accenture, where he honed his skills in product management, marketing, and technical operations. His career began as an engineer at the deepest gold mine in the world, showcasing his ability to tackle challenging environments from the outset. This diverse background has equipped him with a unique perspective and a robust skill set that he has brought to his leadership role at Kardium.

Kevin Chaplin's Education and Expertise

Kevin Chaplin holds a Bachelor of Science degree in Chemical Engineering from the University of Cape Town. This strong academic foundation in engineering has underpinned his technical expertise and problem-solving abilities. His education, combined with his extensive professional experience, has made him a versatile leader proficient in product development, clinical development, and strategic business management. Kevin's engineering background has been particularly beneficial in his role at Kardium, where technical innovation is key to the company's success.

Kevin Chaplin's Achievements

During his tenure at Kardium, Kevin Chaplin has achieved significant milestones, including the successful development and launch of the Globe Mapping and Ablation System. This innovative product has positioned Kardium as a front-runner in atrial fibrillation treatment. Additionally, Kevin has played a crucial role in securing funding and forging strategic partnerships, which have been vital to the company's expansion and continued innovation. His leadership has not only advanced Kardium's technological capabilities but also enhanced its market presence and industry impact.